|
gptkb:Cladribine
|
active chronic infections
|
|
gptkb:Valsartan
|
severe hepatic impairment
|
|
gptkb:Bondronat
|
hypersensitivity to ibandronic acid
|
|
gptkb:Talimogene_laherparepvec
|
immunocompromised patients
|
|
gptkb:mephenytoin
|
gptkb:porphyria
|
|
gptkb:BromSite
|
hypersensitivity to bromfenac or NSAIDs
|
|
gptkb:Revia
|
liver failure
|
|
gptkb:Sirdalud
|
concomitant use with CYP1A2 inhibitors
|
|
gptkb:pegylated_interferon_alpha
|
severe psychiatric disorders
|
|
gptkb:Ramipril
|
pregnancy
|
|
gptkb:carprofen
|
use with other NSAIDs
|
|
gptkb:Bayer_Aspirin_(U.S._rights)
|
bleeding disorders
|
|
gptkb:pindolol
|
asthma
|
|
gptkb:drospirenone
|
hepatic impairment
|
|
gptkb:Lansoprazole
|
hypersensitivity to lansoprazole
|
|
gptkb:Dynavel_XR
|
advanced arteriosclerosis
|
|
gptkb:DB00624
|
acute or chronic metabolic acidosis
|
|
gptkb:tenofovir_disoproxil_fumarate
|
severe renal impairment
|
|
gptkb:pyridostigmine
|
mechanical intestinal obstruction
|
|
gptkb:Monistat_3
|
allergy to miconazole
|